Song Qu

2.0k total citations
97 papers, 1.1k citations indexed

About

Song Qu is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Song Qu has authored 97 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Otorhinolaryngology, 46 papers in Oncology and 36 papers in Surgery. Recurrent topics in Song Qu's work include Head and Neck Cancer Studies (54 papers), Head and Neck Surgical Oncology (22 papers) and Lung Cancer Treatments and Mutations (15 papers). Song Qu is often cited by papers focused on Head and Neck Cancer Studies (54 papers), Head and Neck Surgical Oncology (22 papers) and Lung Cancer Treatments and Mutations (15 papers). Song Qu collaborates with scholars based in China, Netherlands and Australia. Song Qu's co-authors include Xiaodong Zhu, Zhongguo Liang, Kai-Hua Chen, Yanming Jiang, Xiao‐Dong Zhu, Ling Li, Shi‐Ting Huang, Fang Su, Liang Xia and Binbin Yu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Song Qu

94 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Song Qu China 19 480 419 313 264 262 97 1.1k
Takatsugu Mizumachi Japan 20 346 0.7× 478 1.1× 388 1.2× 221 0.8× 422 1.6× 67 1.2k
Zhongguo Liang China 15 271 0.6× 307 0.7× 176 0.6× 171 0.6× 223 0.9× 69 711
Cheng–Lung Hsu Taiwan 17 284 0.6× 291 0.7× 307 1.0× 296 1.1× 204 0.8× 33 1.2k
Wei‐Han Hu China 16 280 0.6× 362 0.9× 104 0.3× 252 1.0× 223 0.9× 44 762
Wei‐Xiong Xia China 19 408 0.8× 430 1.0× 188 0.6× 208 0.8× 216 0.8× 65 912
Jay P. Reddy United States 18 356 0.7× 223 0.5× 215 0.7× 322 1.2× 253 1.0× 94 1.1k
Marine Lefèvre France 18 291 0.6× 121 0.3× 314 1.0× 424 1.6× 214 0.8× 67 1.1k
Shixiu Wu China 23 496 1.0× 212 0.5× 624 2.0× 545 2.1× 408 1.6× 71 1.6k
Henry Sze China 19 560 1.2× 1.0k 2.4× 218 0.7× 533 2.0× 621 2.4× 30 1.5k
Andreas Schröck Germany 19 327 0.7× 131 0.3× 410 1.3× 189 0.7× 171 0.7× 47 946

Countries citing papers authored by Song Qu

Since Specialization
Citations

This map shows the geographic impact of Song Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song Qu more than expected).

Fields of papers citing papers by Song Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Song Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song Qu. The network helps show where Song Qu may publish in the future.

Co-authorship network of co-authors of Song Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Song Qu. A scholar is included among the top collaborators of Song Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Song Qu. Song Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Yan, Guohai Yang, Chaojun Zhang, et al.. (2024). A nomogram based on circulating CD8+ T cell and platelet-to-lymphocyte ratio to predict overall survival of patients with locally advanced nasopharyngeal carcinoma. Radiation Oncology. 19(1). 108–108. 3 indexed citations
2.
Chen, Qiuyan, Shanshan Guo, Ying Luo, et al.. (2024). Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study. Oral Oncology. 151. 106723–106723. 11 indexed citations
3.
Sun, Yan, Xiaoli Chai, Zhen Wang, et al.. (2024). First-in-human study of ZG0895, a TLR8 selective agonist, as monotherapy in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e15103–e15103. 1 indexed citations
5.
Zeng, Xiao‐Yi, Zhichao Zuo, Zhongguo Liang, et al.. (2024). Efficacy of metastatic lesion radiotherapy in patients with metastatic nasopharyngeal carcinoma: A multicenter retrospective study. Radiotherapy and Oncology. 196. 110311–110311. 4 indexed citations
7.
Jiang, Yuting, Kai-Hua Chen, Zhongguo Liang, et al.. (2022). A nomogram to predict survival and guide individualized induction chemotherapy in T3-4N1M0 nasopharyngeal carcinoma. Current Problems in Cancer. 46(6). 100897–100897. 3 indexed citations
8.
Chang, Yan, et al.. (2021). A Nomogram Based on Circulating CD4+ T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma. Journal of Inflammation Research. Volume 14. 6707–6718. 6 indexed citations
9.
Huang, Shi‐Ting, et al.. (2021). Maximal lymph nodal diameter on N stage of nasopharyngeal carcinoma. Medicine. 100(26). e26543–e26543. 2 indexed citations
10.
Mai, Hai‐Qiang, Shaojun Lin, Dongping Chen, et al.. (2021). 436 A phase II study of AK104, a bispecific antibody targeting PD-1 and CTLA-4, in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy. Regular and Young Investigator Award Abstracts. A466–A466. 14 indexed citations
11.
Liang, Zhongguo, Fan Zhang, Li Ye, et al.. (2021). The Integration of the Pre-Treatment Neutrophil-to-Lymphocyte Ratio in the Eighth Edition of the AJCC Staging System for Nasopharynx Cancer. Frontiers in Oncology. 11. 724467–724467. 2 indexed citations
13.
Zhu, Xiaodong, Ling Li, Zhongguo Liang, et al.. (2020). Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs. Scientific Reports. 10(1). 5161–5161. 14 indexed citations
14.
Jiang, Yanming, et al.. (2020). Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma. Scientific Reports. 10(1). 861–861. 19 indexed citations
15.
Sun, Yongchu, Lin Huan, Song Qu, et al.. (2019). <p>Downregulation of CD166 inhibits invasion, migration, and EMT in the radio-resistant human nasopharyngeal carcinoma cell line CNE-2R</p>. Cancer Management and Research. Volume 11. 3593–3602. 7 indexed citations
16.
Su, Fang, Kai-Hua Chen, Zhongguo Liang, et al.. (2019). <p>Survival benefit of higher fraction dose delivered by three-dimensional conformal radiotherapy in hepatocellular carcinoma smaller than 10 cm in size</p>. Cancer Management and Research. Volume 11. 3791–3799. 4 indexed citations
17.
Li, Ling, Song Qu, Wei Zhao, et al.. (2015). Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2. Oncology Reports. 34(5). 2477–2488. 12 indexed citations
18.
Li, Ling, Shi‐Ting Huang, Xiaodong Zhu, et al.. (2013). Identification of Radioresistance-Associated Proteins in Human Nasopharyngeal Carcinoma Cell Lines by Proteomic Analysis. Cancer Biotherapy and Radiopharmaceuticals. 28(5). 380–384. 13 indexed citations
19.
Su, Fang, Xiaodong Zhu, Song Qu, et al.. (2013). Analysis of serum proteome profiles in nasopharyngeal carcinoma with different radiosensitivity. Clinical & Translational Oncology. 16(2). 147–152. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026